February 07, 2012; 78 (6) Articles
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
M. Anheim, A. Elbaz, S. Lesage, A. Durr, C. Condroyer, F. Viallet, P. Pollak, B. Bonaïti, C. Bonaïti-Pellié, A. Brice
First published January 25, 2012, DOI: https://doi.org/10.1212/WNL.0b013e318245f476
M. Anheim
A. Elbaz
S. Lesage
A. Durr
C. Condroyer
F. Viallet
P. Pollak
B. Bonaïti
C. Bonaïti-Pellié
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
M. Anheim, A. Elbaz, S. Lesage, A. Durr, C. Condroyer, F. Viallet, P. Pollak, B. Bonaïti, C. Bonaïti-Pellié, A. Brice
Neurology Feb 2012, 78 (6) 417-420; DOI: 10.1212/WNL.0b013e318245f476
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 78 no. 6 417-420
PubMed:
Print ISSN:
Online ISSN:
History:
- Received July 8, 2011
- Accepted September 29, 2011
- First Published January 25, 2012.
Article Versions
- Previous version (January 25, 2012 - 13:02).
- You are viewing the most recent version of this article.
Copyright & Usage:
Copyright © 2012 by AAN Enterprises, Inc.
Author Disclosures
- M. Anheim, MD, PhD,
- A. Elbaz, MD, PhD,
- S. Lesage, PhD,
- A. Durr, MD, PhD,
- C. Condroyer, BS,
- F. Viallet, MD, PhD,
- P. Pollak, MD,
- B. Bonaïti, MSc,
- C. Bonaïti-Pellié, MD, PhD and
- A. Brice, MD On behalf of the French Parkinson Disease Genetic Group
- M. Anheim, MD, PhD,
- A. Elbaz, MD, PhD,
- S. Lesage, PhD,
- A. Durr, MD, PhD,
- C. Condroyer, BS,
- F. Viallet, MD, PhD,
- P. Pollak, MD,
- B. Bonaïti, MSc,
- C. Bonaïti-Pellié, MD, PhD and
- A. Brice, MD On behalf of the French Parkinson Disease Genetic Group
- From INSERM, U975 (M.A., S.L., A.D., C.C., A.B.), Paris, France; Pierre and Marie Curie-Paris 6 Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, Pitié-Salpêtrière (M.A., S.L., A.D., C.C., A.B.), Paris, France; Cnrs, UMR 7225, Paris, France (M.A., S.L., A.D., C.C., A.B.); AP-HP, Pitié-Salpêtrière Hospital, Department of Genetics and Cytogenetics (M.A., A.D., A.B.), Paris, France; Centre de Référence des Maladies Neurogénétiques de l'Enfant et de l'Adulte (M.A., A.D., A.B.), Paris, France; INSERM, U708, Neuroepidemiology, F-75013 (A.E.), Paris, France; UPMC University Paris 06, UMR_S708, Neuroepidemiology, F-75005 (A.E.), Paris, France; Department of Neurology (F.V.), Aix-en-Provence, France; Neurology Department (P.P.), Geneva, Switzerland; INRA-GABI, F-78352 (B.B.), Jouy-en-Josas, France; INSERM, U669, F-94807 (B.B., C.B.-P.), Villejuif, France; and University of Paris-Sud, F-94807 (C.B.-P.), Villejuif, France.
- Correspondence & reprint requests to Prof. Brice: alexis.brice{at}upmc.fr
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
- Gaucher and Parkinsonism: Blurred boundaries Between Mendelian and Complex Disorders
- Ellen Sidransky, Chief, Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, NIHsidranse@mail.nih.gov
- Ellen Sidransky, Bethesda, MD; P.Suzanne Hart, Bethesda, MD
Submitted March 16, 2012
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.